BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 10452936)

  • 21. The molecular genetics of gyn malignancies.
    Taylor RR; Teneriello MG; Nash JD; Park RC; Birrer MJ
    Oncology (Williston Park); 1994 Oct; 8(10):63-70, 73; discussion 73, 78-82. PubMed ID: 7803216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of PET in gynecologic malignancy.
    Grigsby PW
    Curr Opin Oncol; 2009 Sep; 21(5):420-4. PubMed ID: 19553814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mass screening of gynecological cancers in public health].
    Solignac M
    Presse Med; 2003 Jan; 32(2):88-91. PubMed ID: 12653035
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan.
    Koong SL; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S44-7. PubMed ID: 17227642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pill and gynecologic cancer: controversy and mystery prevail.
    Sargent MA
    J Med Assoc Ga; 1995 Sep; 84(7):320-2. PubMed ID: 7561539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gynaecological cancers in Umbria (Italy): trends of incidence, mortality and survival, 1978-1998.
    Minelli L; Stracci F; Prandini S; Moffa IF; La Rosa F
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):59-65. PubMed ID: 15223167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Routine cancer screening. ACOG Committee Opinion: Committee on Gynecologic Practice number 128--October 1993.
    Int J Gynaecol Obstet; 1993 Dec; 43(3):344-8. PubMed ID: 7907052
    [No Abstract]   [Full Text] [Related]  

  • 28. Screening for cervical cancer.
    Higgins C
    Nurs Times; 1997 May 14-20; 93(20):50-1. PubMed ID: 9197757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for gynecologic cancer.
    Campion MJ; Reid R
    Obstet Gynecol Clin North Am; 1990 Dec; 17(4):695-727. PubMed ID: 2092238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Screening for gynecologic cancer].
    Yajima A; Sato S; Masuda K; Nagai H; Mori T
    Gan No Rinsho; 1990 Aug; 36(10):1128-32. PubMed ID: 2214149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer screening in Singapore, with particular reference to breast, cervical and colorectal cancer screening.
    Yeoh KG; Chew L; Wang SC
    J Med Screen; 2006; 13 Suppl 1():S14-9. PubMed ID: 17227636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New tests for cervical cancer screening.
    Nuovo J; Melnikow J; Howell LP
    Am Fam Physician; 2001 Sep; 64(5):780-6. PubMed ID: 11563569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian, uterine, and cervical cancer in the elderly woman.
    McGonigle KF; Lagasse LD; Karlan BY
    Clin Geriatr Med; 1993 Feb; 9(1):115-30. PubMed ID: 8443730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACS releases updated guidelines on cancer screening.
    Lambert M
    Am Fam Physician; 2012 Sep; 86(6):571, 576-7. PubMed ID: 23062051
    [No Abstract]   [Full Text] [Related]  

  • 35. [Status of screening tests for cervical cancer and its precancerous lesion].
    Zhao FH; Rong SD; Qiao YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):638-41. PubMed ID: 12901114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mass screening of the uterine cervix in the program of the "Decade of Health": perspectives of gynecologic cancer screening in Hungary].
    Országos Tisztifóorvosi Hivatal Méhnyakszúrési Munkacsoport
    Orv Hetil; 2004 Jan; 145(1):35-40. PubMed ID: 15222140
    [No Abstract]   [Full Text] [Related]  

  • 37. Social inequality and incidence of and survival from cancer of the female genital organs in a population-based study in Denmark, 1994-2003.
    Jensen KE; Hannibal CG; Nielsen A; Jensen A; Nøhr B; Munk C; Kjaer SK
    Eur J Cancer; 2008 Sep; 44(14):2003-17. PubMed ID: 18662869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Screening in gynecologic oncology].
    Ebeling K
    Zentralbl Gynakol; 1983; 105(19):1225-38. PubMed ID: 6316692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk-adapted multimodal laboratory cervical screening -- application of new technologies to cervical cancer prevention.
    Bollmann R; Bankfalvi A; Bollmann M
    Croat Med J; 2005 Jun; 46(3):361-7. PubMed ID: 15861512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical applications of urinary gonadotropin peptides (UGP) in gynecologic oncology.
    Schwartz PE; Cracchiolo BM; Cole LA
    Anticancer Res; 1996; 16(4B):2135-9. PubMed ID: 8694533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.